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Background: Coronary artery disease (CAD) is a major cardiovascular complication in diabetic patients. Despite the
significant association between obesity and diabetes, the majority of the diabetic subjects are not obese in an Asian
population. This study evaluated the association between obesity and coronary artery disease (CAD) according to
the diabetes status in a Korean population.
Methods: The association between obesity and CAD using the parameters of any plaque, obstructive plaque, and
coronary artery calcium score (CACS) >100 according to the presence of diabetes was evaluated in 7,234 Korean
adults who underwent multi-detector computed tomography for general health evaluations. Obesity was defined
as a body mass index (BMI) ≥25 kg/m2.
Results: The prevalence of obesity was significantly higher in diabetic subjects than in non-diabetic subjects, but the
majority of the diabetic subjects were non-obese (48% vs. 37%, p <0.001). The incidence of any plaque (58% vs. 29%),
obstructive plaque (20% vs. 6%), and CACS >100 (20% vs. 6%) were significantly higher in diabetic patients than
in non-diabetic subjects (p <0.001, respectively). Incidence of any plaque (33% vs. 26%, p <0.001), obstructive
plaque (7% vs. 6%, p = 0.014), and CACS >100 (8% vs. 6%, p = 0.002) was significantly higher in non-diabetic subjects
with obesity than in those without obesity, but the incidence of all coronary parameters was not different in diabetic
subjects according to the obesity status. After adjusting for confounding risk factors including age, gender,
hypertension, dyslipidemia, current smoking, and mild renal dysfunction, obesity was independently associated
with increased risks of any plaque (OR 1.14) and CACS >100 (OR 1.31) only in non-diabetic subjects (p <0.05,
respectively). Multiple logistic regression models revealed that diabetes was independently associated with all coronary
parameters.
Conclusion: Despite a significantly higher prevalence of obesity in diabetic subjects than in non-diabetic subjects,
obesity is associated with the presence of any plaque and severe coronary calcification only in subjects without
established diabetes among Korean population.
Keywords: Obesity, Diabetes, Coronary artery disease, Cardiac computed tomographic angiography* Correspondence: hjchang@yuhs.ac
1Division of Cardiology, Yonsei Cardiovascular Center, Yonsei University
College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Republic
of Korea
5Severance Biomedical Science Institute, Seoul, Republic of Korea
Full list of author information is available at the end of the article
© 2014 Won et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Won et al. Diabetology & Metabolic Syndrome 2014, 6:134 Page 2 of 9
http://www.dmsjournal.com/content/6/1/134Background
Diabetes is significantly associated with an increased
risk of coronary artery disease (CAD). Although the
pathogenesis of diabetes is complicated by multiple
metabolism-related problems, a deterioration of insulin
secretion and an aggravation of insulin resistance are 2
central defects in the pathogenesis of diabetes [1,2]. It
is obvious that obesity is one of the major factors for
insulin resistance. However, the criterion of obesity is
dependent on ethnicity, and the prevalence of obesity
differs according to ethnicity. In addition, despite the
substantial increases in the prevalence of obesity and
diabetes in Asia, the clinical features of the develop-
ment of diabetes in Asia are explicitly different from
those in other parts of the world, with diabetes devel-
oping in a much shorter time, at a younger age, and in
subjects with much lower body mass index (BMI) in
Asia [3]. The majority of individuals with diabetes are
not obese, even with obesity defined as a BMI of more
than 25 kg/m2, and significant weight loss is observed
during the course of the development of diabetes in
Korean population [4]. Furthermore, several studies on
the pathogenesis of type 2 diabetes reported that im-
paired insulin secretion is more prominent than insulin
resistance, even in the status of impaired glucose toler-
ance [5,6]. Accordingly, whether obesity is an inde-
pendent predictor for CAD in Asian diabetic subjects
may be an important issue, but data are scarce in Asian
populations.
The coronary artery calcium (CAC) score (CACS),
which has developed to quantify the extent of CAC [7],
is a good marker of coronary atherosclerosis [8,9].
CACS is closely correlated with the volume of coronary
plaque measured by autopsy and is considered a surro-
gate marker for the overall coronary plaque burden
[10-12]. A few previous studies investigated the rela-
tionship between obesity and CAC, but the results were
inconsistent. Some reported a positive and independent
association [13-15], while others reported a null [16-18],
or even an inverse association [19]. Furthermore, most
relevant studies were conducted in a Western popula-
tion, in which obesity and CAD are more prevalent
compared with other populations such as East Asian.
In addition, they evaluated the association between
obesity and CAC without considering the status of dia-
betes. Recently, coronary computed tomographic angi-
ography (CCTA) was introduced as a novel noninvasive
imaging approach for evaluating coronary atheroscler-
osis [20,21], and it has high diagnostic accuracy in de-
tecting CAD [22,23]. Therefore, we investigated the
association between obesity and coronary atheroscler-
osis according to diabetes status using the noninvasive
CCTA in Korean subjects with near-normal kidney
function.Methods
Subjects
This cross-sectional study consisted of 8,648 consecu-
tive subjects who had undergone CCTA evaluation with
64-slice multi-detector computed tomography (MDCT)
from January 2004 to April 2009 at Severance Cardio-
vascular Hospital. All subjects were referred for general
health evaluations with following various indications:
symptoms such as chest discomfort, dyspnea, or fatigue;
no symptoms but having abnormal electrocardiographic
test, previous history of peripheral artery disease or
cerebrovascular disease, or the presence of multiple car-
diovascular risk factors. Subjects were excluded for any
one of the following criteria: (a) age < 30 years (n = 69);
(b) established chronic kidney disease or glomerular filtra-
tion rate (GFR) <60 ml/min/1.73 m2, estimated by the
modification of diet in renal disease formula (n = 959);
and (c) insufficient medical records (n = 386). As a re-
sult, 7,234 subjects were included in this study. The
study protocol was approved by the local ethics com-
mittee of our institution.
Protocol of MDCT
Data acquisition and image post-processing were per-
formed in accordance with the Society of Cardiovascular
Computed Tomography guidelines on CCTA acquisition
[24,25]. Briefly, subjects with an initial heart rate ≥65
beats/min before MDCT received a single oral dose
of 50 mg of metoprolol (Betaloc; Yuhan, Seoul, Korea)
1–2 h before CT examination unless β-adrenergic
blocking agents were contraindicated (overt heart fail-
ure, atrioventricular conduction abnormalities, or bron-
chial asthma). Subjects were scanned with a 64-slice
CT scanner (Sensation 64; Siemens Medical Solutions,
Forchheim, Germany). Initially, a non-enhanced pro-
spective electrocardiogram (ECG)-gated scan to evaluate
CACS was performed with the following parameters: rota-
tion time of 330 ms, slice collimation of 0.6 mm, slice
width of 3.0 mm, tube voltage of 100–120 kV, tube
current of 50 mA, and table feed/scan of 18 mm. CCTA
was then performed using retrospective ECG-gating with
the following scan parameters: rotation time of 330 ms,
slice collimation of 64 × 0.6 mm, tube voltage of 100–
120 kV, tube current of 400–800 mA depending on pa-
tient size, table feed/scan of 3.8 mm, and pitch factor of
0.2. ECG-based tube current modulation was applied to
65% of the R–R interval. A real-time bolus-tracking tech-
nique was applied to trigger scan initiation. The total esti-
mated average radiation dose for the multi-slice CT
protocol was 8.7 ± 1.5 mSv. Contrast enhancement was
achieved using 60 mL of iopamidol (370 mg iodine/mL,
Iopamiro; Bracco, Milan, Italy) injected at 5 mL/s,
followed by an injection of 30 mL of diluted contrast
(the ratio of saline to contrast agent was 7:3) and then
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CT; Medrad, Indianola, PA) via an antecubital vein.
Image reconstruction was carried out on the scanner
workstation using commercially available software (Wizard;
Siemens Medical Solutions, Forchheim, Germany). Axial
images were reconstructed retrospectively at 65% of the
RR interval for each cardiac cycle. If artifacts were
present, then additional data sets were obtained for
various points of the cardiac cycle, and the data set with
the smallest artifact was selected for further analysis. The
reconstructed image data sets were transferred to an off-
line workstation (Aquarius Workstation; TeraRecon, Inc.,
San Mateo, CA). Each lesion identified was examined
using maximum-intensity projection and multiplanar re-
construction techniques on a short axis and along mul-
tiple longitudinal axes. Lesions were classified by the
maximal stenosis of the luminal diameter observed on any
plane.
Measurement of CT variables
CCTA data were evaluated by 2 experienced cardiac radi-
ologists (Y.J.K. and B.W.C., who have 6 and 9 years of ex-
perience in cardiac CT, respectively). This study primarily
evaluated the presence of any plaque, obstructive plaque,
and CACS >100. Both any plaque and obstructive plaque
were divided into 2 subtypes according to the presence of
coronary calcification following calcified or mixed plaque
and non-calcified plaque, respectively. CACS was mea-
sured using a previously described method [7]. Because
the frequency of CACS >100 in the Asian population is
known to be lower than that in Caucasians, African-
Americans, and Hispanics [26], we used CACS >100 as
the parameter for identifying severe coronary calcification.
Plaque was defined as structures >1 mm2 within and/or
adjacent to the vessel lumen that were clearly distin-
guished from the lumen and surrounding pericardial tis-
sue. Obstructive plaque was defined as plaque with ≥50%
luminal diameter stenosis. Calcified plaque was defined
as plaque occupied by calcified tissue for ≥50% of the
plaque area (density >130 Hounsfield units in native
scans). Mixed calcified plaque was defined as plaque in
which <50% of the area is occupied by calcified tissue.
Plaque without any calcium was defined as non-calcified
plaque. CAD was defined as the presence of any coronary
plaque and calcium identified by CCTA.
Measurement of clinical variables
Medical histories of hypertension, dyslipidemia, diabetes,
and smoking status were systematically acquired for the
subjects. Height, weight, and blood pressure were mea-
sured during visits. All blood samples, including those for
triglycerides, high-density lipoprotein (HDL) cholesterol,
low-density lipoprotein (LDL) cholesterol, and glucose,
were obtained after a 12-h fast on the day of the CT scanas part of the clinical work-up. BMI was calculated as
weight (kg) ÷ height (m2), and obesity was defined as a
BMI ≥25 kg/m2. Hypertension was defined as systolic
blood pressure ≥140 mmHg and/or diastolic blood pres-
sure ≥90 mmHg or the use of antihypertensive treatment.
Dyslipidemia was defined as total cholesterol ≥240 mg/dL,
LDL ≥130 mg/dL, HDL ≤40 mg/dL, TG ≥150 mg/dL, or
treatment with lipid-lowering agents. Current smoking
history was considered present if subjects consistently
smoked or smoked within 1 month before the study. Mild
renal dysfunction was defined as a GFR of 60–89 ml/min/
1.73 m2. Diabetes was defined as fasting glucose ≥126 mg/
dL, the receipt of antidiabetic treatment, or a referral diag-
nosis of diabetes.Statistical analysis
Continuous variables are expressed as the mean ± SD or
medians and interquartile range according to the distribu-
tion. Categorical variables are presented as n (%). Con-
tinuous variables were compared using an independent
t-test or Mann-Whitney’s U-test, and categorical vari-
ables were compared using the χ2 test or Fisher’s exact
test, as appropriate. Univariate and multivariate logistic
regression analysis for evaluating the impact of obesity
and BMI on the presence of any plaque, obstructive
plaque, and CACS <100 were performed separately for
subjects with and without diabetes. Multivariate logistic
regression analysis was adjusted for confounding risk
factors including age, gender, hypertension, dyslipidemia,
current smoking, and mild renal dysfunction. And, multi-
variate logistic models were analyzed to identify the im-
pact of diabetes on the presence of any plaque, obstructive
plaque, and CACS <100. The covariate-adjusted odds ra-
tio (OR) and 95% confidence intervals (CI) for each par-
ameter were calculated. SPSS version 18 (SPSS Inc.,
Chicago, IL) was used for all statistical analyses, and
p <0.05 was considered significant.Results
The clinical characteristics of the 7,234 subjects (52 ±
10 years; 57% men) are listed in Table 1. There were 6,345
non-diabetic (88%) and 889 diabetic subjects (12%). The
overall prevalence of obesity in the present study was 38%.
The prevalence of obesity was significantly higher in dia-
betic subjects than in non-diabetic subjects (48% vs. 37%,
p <0.001), but the majority of diabetic subjects were non-
obese (Figure 1). The prevalence of hypertension, and dys-
lipidemia were significantly higher in diabetic subjects
than in non-diabetic subjects (p <0.001, respectively). The
incidence of any plaque (58% vs. 29%), obstructive plaque
(20% vs. 6%), and CACS >100 (20% vs. 6%) were signifi-
cantly higher in diabetic patients than in non-diabetic sub-
jects (p <0.001, respectively) (Figure 2).
Table 1 Baseline characteristics
Non-diabetes (n = 6,345) Diabetes (n = 889) P
Age (years) 52 ± 10 58 ± 9 <0.001
Men, n (%) 3569 (56) 565 (64) <0.001
BMI (kg/m2) 24.1 ± 2.9 25.1 ± 3.1 <0.001
BMI <18.5 99 (2) 10 (1)
BMI 18.5 – 24.9 3920 (61) 455 (51)
BMI 25.0 – 29.9 2137 (34) 373 (42)
BMI ≥30.0 189 (3) 51 (6)
Obesity, n (%) 2326 (37) 424 (48) <0.001
Hypertension, n (%) 1716 (27) 427 (49) <0.001
Current smoking, n (%) 1351 (22) 186 (21) 0.801
Dyslipidemia, n (%) 3253 (52) 560 (64) <0.001
Total cholesterol (mg/dL) 187 (164, 210) 177 (155, 203) <0.001
Triglyceride (mg/dL) 121 (87, 170) 135 (97, 187) <0.001
HDL cholesterol (mg/dL) 50 (43, 58) 48 (41, 54) <0.001
LDL cholesterol (mg/dL) 119 (97, 141) 111 (89, 137) 0.007
Creatinine (mg/dL) 0.90 (0.80, 1.00) 0.90 (0.80, 1.00) <0.001
GFR (ml/min/1.73 m2) 80 (72, 91) 80 (72, 90) <0.001
FBS (mg/dL) 94 (88, 101) 127 (107, 149) <0.001
Any plaque, n (%) 1814 (29) 511 (58) <0.001
Obstructive plaque, n(%) 401 (6) 174 (20) <0.001
CACS >100, n (%) 403 (6) 176 (20) <0.001
Data are expressed as n (%) or mean ± SD. BMI, body mass index; CACS, coronary artery calcium score; FBS, fasting blood sugar; GFR, glomerular filtration rate;
HDL, high-density lipoprotein; LDL, low-density lipoprotein.
Figure 1 Comparison of the prevalence of obesity according to the diabetes status.
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Figure 2 Comparison of the incidence of coronary parameters according to the diabetes status.
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obstructive plaque (7% vs. 6%, p = 0.014), and CACS >100
(8% vs. 6%, p = 0.002) was significantly higher in non-
diabetic subjects with obesity than those without obesity.
However, there were no significant differences in all these
parameters according to the obesity in diabetic subjects
(Table 2).
Univariate logistic regression analysis revealed that
obesity and BMI were significantly associated with in-
creased risks of any plaque (obesity: odd ratio [OR] 1.36,
p <0.001; BMI: OR 1.08, p <0.001), obstructive plaque
(obesity: OR 1.29, p = 0.014, BMI: OR 1.07, p <0.001), and
CACS >100 (obesity: OR 1.38, p = 0.002; BMI: OR 1.07,
p <0.001) in non-diabetic subjects. However, neither obes-
ity nor BMI were significantly associated with increased
risks of any plaque (obesity: OR 1.14, p = 0.323; BMI: OR
0.98, p = 0.249), obstructive plaque (obesity: OR 1.12, p =
0.496, BMI: OR 0.97, p = 0.342), and CACS >100 (obesity:
OR 0.92, p = 0.610; BMI: OR 0.95, p = 0.083) in diabetic
subjects. After adjusting for age, gender, hypertension,
dyslipidemia, current smoking, and mild renal dysfunc-
tion, both obesity and BMI were significantly associated
with increased risks of any plaque (obesity: OR 1.14, p =
0.039; BMI: OR 1.04, p = 0.003) and CACS >100 (obesity:
OR 1.31, p = 0.019; BMI: OR 1.06, p = 0.004), but notTable 2 Comparison of coronary atherosclerosis according to
Non-diabetes (n = 6,345)
Non-obesity (n = 4,019) Obesity (n = 2,32
Any plaque, n (%) 1055 (26) 759 (33)
CMP 785 (19) 586 (26)
NCP 270 (7) 173 (7)
Obstructive plaque, n (%) 231 (6) 170 (7)
Obstructive CMP 190 (5) 143 (6)
Obstructive NCP 41 (1) 27 (1)
CACS >100, n (%) 226 (6) 177 (8)
Data are expressed as n (%). CACS, coronary artery calcium score; CMP, calcified orsignificantly associated with obstructive plaque (obesity:
OR 1.16, p = 0.202; BMI: OR 1.04, p = 0.096) in non-
diabetic subjects. However, neither obesity nor BMI were
significantly associated with increased risks of any plaque
(obesity: OR 1.26, p = 0.131; BMI: OR 1.00, p = 0.903), ob-
structive plaque (obesity: OR 1.19, p = 0.332; BMI: OR
0.99, p = 0.775), and CACS >100 (obesity: OR 1.08, p =
0.685; BMI: OR 0.99, p = 0.685) in diabetic subjects
(Table 3 and Figure 3).
Multivariate logistic models for identifying the impact
of diabetes on the presence of any plaque, obstructive
plaque, and CACS <100 were analyzed after consecu-
tively adjusting for age, gender, hypertension, BMI, dys-
lipidemia, current smoking, and mild renal dysfunction.
All models illustrated that diabetes had a strong impact
on the presence of any plaque, obstructive plaque, and
CACS >100 (Table 4).
Discussion
To the best of our knowledge, the present study is the first
to provide information on the differential association be-
tween obesity and coronary atherosclerosis according to
the presence of diabetes in the Asian population. Diabetes
was strongly associated with all coronary parameters in-
cluding any plaque, obstructive plaque, and CACS >100.the obesity status in non-diabetic and diabetic subjects
P Diabetes (n = 889) P
6) Non-obesity (n = 465) Obesity (n = 424)
<0.001 260 (56) 251 (59) 0.323
<0.001 226 (49) 209 (50) 0.837
0.278 34 (7) 42 (9) 0.167
0.014 87 (19) 87 (21) 0.496
0.015 77 (17) 71 (17) 0.940
0.601 10 (2) 16 (4) 0.151
0.002 95 (21) 81 (19) 0.610
mixed plaque; NCP, non-calcified plaque.
Table 3 Impact of obesity and BMI on coronary atherosclerosis according to the diabetes status
Any plaque Obstructive plaque CACS >100
Univariate Multivariate Univariate Multivariate Univariate Multivariate
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Non-diabetes
Obesity 1.36 1.22–1.52* 1.14 1.01–1.30‡ 1.29 1.05–1.59† 1.16 0.93–1.44 1.38 1.13–1.69† 1.31 1.05–1.65‡
BMI 1.08 1.06–1.10* 1.04 1.01–1.06† 1.07 1.03–1.10* 1.04 0.99–1.08 1.07 1.04–1.11* 1.06 1.02–1.11†
Diabetes
Obesity 1.14 0.88–1.49 1.26 0.93–1.70 1.12 0.81–1.56 1.19 0.84–1.70 0.92 0.66–1.23 1.08 0.75–1.56
BMI 0.98 0.93–1.02 1.00 0.95–1.05 0.97 0.92–1.03 0.99 0.93–1.05 0.95 0.90–1.01 0.99 0.93–1.05
BMI, body mass index; CACS, coronary artery calcium score; CI, confidence interval; OR, odds ratio.
Multivariate analyses were adjusted for age, gender, hypertension, dyslipidemia, current smoking, and mild renal dysfunction.
*P <0.001, †P <0.005, ‡P <0.05.
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betic subjects, obesity was independently associated with
the presence of CAD and severe coronary calcification
only in subjects without established diabetes in a Korean
population.
Obesity, a major factor for insulin resistance, is signifi-
cantly associated with diabetes and CAD [27,28]. How-
ever, the criteria and prevalence of obesity is dependent
on ethnicity. Despite the increased prevalence of obesity
and diabetes in Asia, the clinical features of the develop-
ment of diabetes in Asia are different from those in
other parts of the world [3]. In Korea, previous studies
reported that approximately 65% of subjects with dia-
betes were non-obese [4], and that impaired insulin se-
cretion was more prominent than insulin resistance in
diabetic subjects [5,6]. Furthermore, a recent study re-
vealed that diabetes had an incremental impact on sub-
clinical atherosclerosis independent of the metabolic
syndrome, for which insulin resistance is a major char-
acteristic, in the Korean population [29]. Accordingly, it
is important to identify whether obesity is independ-
ently associated with CAD in an Asian population with
established diabetes.Figure 3 Association between obesity and coronary parameters. (A) NCAC is a traditional surrogate marker for coronary
atherosclerosis because it is significantly related to the
coronary plaque burden [10,11]. It may be that the se-
verity of coronary calcification is somewhat different in
an Asian population compared to that in a Western
population [26]. However, most studies evaluated the
association between obesity and CAC in a Western
population with conflicting results [13-19]. CCTA has
recently been used for evaluating coronary atheroscler-
osis because of its high diagnostic accuracy in detecting
CAD [22,23], and only limited studies investigated the
relationship of BMI with coronary atherosclerosis using
CCTA. Dores et al. [30] reported that BMI was an inde-
pendent predictor of CAD, but it was not correlated
with the severity of CAD in subjects with suspected
CAD. Labounty et al. [31] reported that an increased
BMI was associated with a greater prevalence, extent,
and severity of CAD and was independently associated
with an increased risk of myocardial infarction. However,
most participants in these studies were from Western
populations, and these studies did not evaluate the differ-
ential association of BMI with coronary atherosclerosis ac-
cording to the presence of diabetes. Furthermore, it hason-diabetes, (B) diabetes.
Table 4 Multiple logistic regression models for identifying
the impact of diabetes on coronary atherosclerosis
Any plaque Obstructive plaque CACS >100
OR 95% CI OR 95% CI OR 95% CI
Model 1 3.38 2.93–3.90* 3.61 2.97–4.39* 3.65 3.01–4.43*
Model 2 2.37 2.03–2.77* 2.43 1.98–2.98* 2.25 1.82–2.77*
Model 3 2.21 1.88–2.59* 2.32 1.89–2.85* 2.15 1.74–2.67*
Model 4 2.10 1.79–2.47* 2.21 1.80–2.73* 2.08 1.68–2.59*
Model 5 2.05 1.75–2.41* 2.17 1.67–2.76* 2.04 1.64–2.53*
Model 6 2.00 1.70–2.35* 2.12 1.71–2.61* 2.06 1.66–2.56*
Model 7 2.01 1.71–2.36* 2.14 1.73–2.64* 2.08 1.67–2.58*
Model 8 1.96 1.67–2.31* 2.07 1.67–2.56* 2.05 1.65–2.55*
BMI, body mass index; CACS, coronary artery calcium score; CI, confidence
interval; OR, odds ratio. *P <0.001.
Model 1: Unadjusted.
Model 2: Adjusted for age.
Model 3: Adjusted for age and gender.
Model 4: Adjusted for age, gender, and hypertension.
Model 5: Adjusted for age, gender, hypertension, and BMI.
Model 6: Adjusted for age, gender, hypertension, BMI, and dyslipidemia.
Model 7: Adjusted for age, gender, hypertension, BMI, dyslipidemia, and
current smoking.
Model 8: Adjusted for age, gender, hypertension, BMI, dyslipidemia, current
smoking, and mild renal dysfunction.
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BMI ≥25 kg/m2, is an independent predictor of CAD in
Asian patients with diabetes. We evaluated the associ-
ation between obesity and coronary atherosclerosis using
the parameters of any plaque, obstructive plaque, and
CACS >100 according to the presence of diabetes. The
prevalence of obesity was significantly higher in diabetic
subjects than in non-diabetic subjects, but the majority of
diabetic subjects were non-obese in our Korean popula-
tion. We identified that diabetes was strongly associated
with all coronary atherosclerotic parameters. Despite a
significantly higher prevalence of obesity in diabetic sub-
jects than in non-diabetic subjects, obesity was independ-
ently associated with the presence of CAD and severe
coronary calcification in non-diabetic subjects. These re-
sults suggest that obesity is not a useful predictor for
CAD in subjects with established diabetes, although it was
significantly associated with the development of diabetes
in a Korean population. These results might imply that
the identification of newly developing diabetes might be
important in non-diabetic subjects with obesity; however,
considering the incremental impact of diabetes on coron-
ary atherosclerosis, rigorous risk stratification for CAD is
necessary in subjects with established diabetes irrespective
of the obesity status in the Korean population.
Although obesity is associated with an increased risk of
cardiovascular disease [32,33], several studies have sug-
gested an interesting phenomenon, the obesity paradox,
which is the protective effect of obesity against adverse
clinical outcomes in patients with obstructive CAD
[34-36]. However, these studies evaluated the impact ofobesity on prognosis only in patients with established
CAD. In the present study, diabetes was independently
associated with the presence and severity of CAD, but
obesity was not independently associated with CAD in
subjects with established diabetes. Although the rela-
tionship between obesity and prognosis in subjects with
diabetes remains uncertain in the Asian population, it
may be more important to predict the development of
CAD in non-obese subjects with diabetes compared
with their obese counterparts considering the protect-
ive effect of obesity in subjects with obstructive CAD.
Further prospective studies with larger sample sizes are
necessary to address this issue.
Limitations
Several limitations should be acknowledged in the present
study. First, we could not eliminate the possible effects of
underlying medication for hypertension, dyslipidemia, and
diabetes on coronary atherosclerosis because of the obser-
vational design of this study. Second, we used only the cri-
terion of BMI ≥25 kg/m2 for defining the obesity status.
Although it is well-known that BMI is significantly associ-
ated with abdominal fat and waist circumference in the
Korean population [37], further evaluation of the associ-
ation between other anthropometric indices and coronary
atherosclerosis according to the presence of diabetes may
be necessary in Asian populations.
Despite these limitations, it is novel in that only partici-
pants of Asian ethnicity were evaluated in the present
study compared with other studies performed in Western
populations. In addition, the clinical usefulness of obesity
for predicting CAD according to the diabetes status was
first evaluated in approximately 7,300 Asian subjects with
near-normal kidney function using large-scale CT data.
The findings of this study may be helpful to identify the
differential association between obesity and CAD accord-
ing to the diabetes status in the Asian population.
Conclusions
Despite a significantly higher prevalence of obesity in dia-
betic subjects than in non-diabetic subjects, the majority
of the diabetic subjects were non-obese in our Korean
population. Obesity has an independent predictive value
for the presence of CAD and severe coronary calcification
only in subjects without established diabetes. Considering
the incremental impact of diabetes, rigorous risk stratifica-
tion for CAD might be necessary in diabetic subjects irre-
spective of the obesity status among Asian population.
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